Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Capital Hilton

Oct 28, 2024 7:00 AM - Oct 30, 2024 7:00 PM

1001 16th Street NW, , Washington, DC 20036-5794 , USA

DIA/FDA Oligonucleotide-Based Therapeutics Conference

Call for Posters and Roundtables Ends

DAYS

HOURS

MINUTES

SECONDS

Highlights & Features

What is happening at FDA/DIA Oligonucleotide-Based Therapeutics Conference


Need Approval in Order to Attend?

Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.


Call for Posters

Get involved! DIA and the Program Committee invite you to submit a poster abstract to be presented during the DIA/FDA Oligonucleotide-Based Therapeutics Conference, October 28-30. Posters describing research, best practices, or approaches related to oligonucleotides in areas of Clinical, Non-Clinical, and CMC will be considered for acceptance.

Call for Roundtable Discussion Leaders

The program committee invites you to propose and volunteer to lead a roundtable luncheon discussion at the DIA/FDA Oligonucleotide-Based Therapeutics Conference to be held October 28-30 at the Capital Hilton in Washington, DC. Proposals must be submitted electronically.

Three Track Meeting!


Track 1: Clinical:

There are more than a dozen oligonucleotide based products approved for therapeutic use and nearly 100 currently in clinical testing. Track 1 will explore the lessons learned and the ongoing challenges to clinical use of oligos.

Track 2: Nonclinical:

The nonclinical track will focus on development and safety assessments of oligonucleotide-based therapeutics.

Track 3: CMC:

This track provides an interactive forum for innovators and regulators to present and discuss cutting edge topics in oligonucleotide chemistry, manufacturing, and controls (CMC). The track emphasizes topics that are emerging and will require ongoing collaboration with global regulators. Attendees will take away a deeper understanding of key developments, along with insight into current challenges and successful strategies for navigating this complex area.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.